buPROPion
Drug Name | Form | Strength | Formulary Unrestricted | Formulary Restricted | Non-Formulary | Interchange |
---|---|---|---|---|---|---|
Aplenzin | TABLET, EXTENDED RELEASE, ORAL | hydrobromide 174 mg/24 hours, hydrobromide 348 mg/24 hours | ||||
Aplenzin | TABLET, EXTENDED RELEASE, ORAL | hydrobromide 522 mg/24 hours | ||||
Budeprion SR, Wellbutrin SR, Zyban | TABLET, EXTENDED RELEASE, ORAL | 100 mg/12 hours, 150 mg/12 hours | ||||
Budeprion XL, Buproban, Wellbutrin XL | TABLET, EXTENDED RELEASE, ORAL | 150 mg/24 hours, 300 mg/24 hours | ||||
Wellbutrin | TABLET, ORAL | 75 mg | ||||
Wellbutrin | TABLET, ORAL | 100 mg |
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
Notes
buPROPion (Aplenzin)
buPROPion (Wellbutrin SR)
buPROPion (Wellbutrin)
buPROPion (Wellbutrin SR)
Aplenzin medication guide
Wellbutrin medication guide
Wellbutrin SR medication guide
Wellbutrin XL medication guide
Zyban medication guide
Aplenzin (bupropion bromide) is classified as non-formulary, not stocked.
Dispense the equivalent dose of Wellbutrin SR in its place: Aplenzin 174 mg daily to Wellbutrin SR 150 mg daily. Aplenzin 348 mg daily to Wellbutrin SR 150 mg BID. Aplenzin 522 mg daily to Wellbutrin SR 150 mg q8h.
Reviewed: July 29, 2008 (APLENZIN)
23 February 2016: Bupropion XL interchange is discontinued and will be dispensed as written.
REMS (Zyban): View FDA REMS Info
REMS (buPROPion): View FDA REMS Info